Immune Checkpoint Inhibitors: all 7,814 studies that test it
Page 8 of 79. Open to participants first (2,629), then studies with results posted, then the rest; newest registration first within each.
- CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCsRecruitingNCT07172256Phase 2
- The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CCNot yet recruitingNCT07172217Phase 2
- A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsRecruitingNCT07169994Phase 1/2
- HC010 in First-line PD-L1 Positive Advanced NSCLC PatientsRecruitingNCT07169552Phase 2
- A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical CancerRecruitingNCT07168200Phase 3
- SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal CancerRecruitingNCT07162714Phase 2
- Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative PathologyNot yet recruitingNCT07161453Phase 4
- A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyRecruitingNCT07161414Phase 1
- Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell CarcinomaNot yet recruitingNCT07159191Phase 2
- ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid TumorsRecruitingNCT07158918Phase 1/2
- AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) TreatmentNot yet recruitingNCT07158840Phase 2
- Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLCRecruitingNCT07158489Phase 2
- Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's DiseaseRecruitingNCT07157345Phase 1
- QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon CancerNot yet recruitingNCT07156682Phase 2
- Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine CarcinomaNot yet recruitingNCT07156019Phase 2
- Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME TrialRecruitingNCT07155317Phase 2
- Efficacy and Safety of Serplulimab Combined With Etoposide and Cisplatin as Neoadjuvant Therapy in Limited-Stage Small-Cell Carcinoma of the EsophagealNot yet recruitingNCT07155122Phase 2
- Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast CancerNot yet recruitingNCT07153965Phase 2
- Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)RecruitingNCT07153445Phase 2
- Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell CarcinomaRecruitingNCT07152678Phase 2
- Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract CancerNot yet recruitingNCT07151872Phase 2
- Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung CancerRecruitingNCT07149363Phase 2
- Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal CancerRecruitingNCT07147231Phase 1/2
- A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical CancerNot yet recruitingNCT07143292Phase 2
- Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma PatientsNot yet recruitingNCT07142863Phase 2
- Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid TumorsNot yet recruitingNCT07142837Phase 1/2
- A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral ResectionNot yet recruitingNCT07142200Phase 2
- An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular TypingNot yet recruitingNCT07141771Phase 1/2
- QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody TherapyNot yet recruitingNCT07141186Phase 2
- Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon CancerRecruitingNCT07140679Phase 2
- Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLCNot yet recruitingNCT07139041Phase 2
- Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07136519Phase 2
- Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07135804Phase 2
- A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.RecruitingNCT07134842Phase 1
- A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung CancerRecruitingNCT07133425Phase 2
- Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon CancerNot yet recruitingNCT07132008Phase 3
- A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular CarcinomaNot yet recruitingNCT07131501Phase 2
- Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant MesotheliomaNot yet recruitingNCT07131345Phase 1/2
- SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLCRecruitingNCT07131319Phase 2/3
- A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid TumorsRecruitingNCT07131202Phase 1/2
- A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid TumorsRecruitingNCT07130383Phase 2
- Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT07129772Phase 2
- Botensilimab, Balstilimab, and SBRT in Colorectal CancerRecruitingNCT07128355Early Phase 1
- Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric CancerRecruitingNCT07127822Phase 2
- A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid TumorsRecruitingNCT07126665Phase 1/2
- Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUCRecruitingNCT07126119Phase 2
- A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaRecruitingNCT07123090Phase 2
- Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein ThrombosisRecruitingNCT07122089Phase 2
- Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)RecruitingNCT07120698Phase 2
- Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLCRecruitingNCT07120282Phase 2
- Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer PatientsRecruitingNCT07119996Phase 1
- pReOperative Dostarlimab and Novel Therapies in EndOmetrial CancerNot yet recruitingNCT07115927Phase 2
- A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular CarcinomaNot yet recruitingNCT07115550Not applicable
- A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic CancerRecruitingNCT07114315Phase 2
- QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)Not yet recruitingNCT07113964Phase 2
- Iadademstat + SBRT With Atezo in ES-SCLCRecruitingNCT07113691Phase 1
- A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal CancerRecruitingNCT07113275Phase 3
- A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast CancerRecruitingNCT07111832Phase 3
- A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]RecruitingNCT07111546Phase 2
- A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07111520Phase 1/2
- A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ CancerRecruitingNCT07110571Phase 2
- Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal CarcinomaNot yet recruitingNCT07110558Phase 2
- Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLCRecruitingNCT07110103Phase 2
- DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile CarcinomaRecruitingNCT07110038Phase 2
- Perioperative Immunotherapy for Resectable Limited-Stage SCLCRecruitingNCT07109401Phase 2
- SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast CancerNot yet recruitingNCT07109284Phase 2
- A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)RecruitingNCT07108270Phase 2
- Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast CancerNot yet recruitingNCT07107217Phase 2
- Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II TrialRecruitingNCT07106034Phase 2
- HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)RecruitingNCT07105748Phase 2
- A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell CarcinomaRecruitingNCT07105592Phase 1/2
- Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBCNot yet recruitingNCT07103447Phase 2
- A PHASE II, RANDOMIZED TRIAL TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT VULVAR CANCERNot yet recruitingNCT07101848Phase 2
- A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCERNot yet recruitingNCT07101822Phase 2
- Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical TrialRecruitingNCT07101744Phase 2
- A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).Not yet recruitingNCT07101614Phase 2
- Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of NivolumabRecruitingNCT07100704Phase 2
- Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabRecruitingNCT07100392Phase 2
- Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract CarcinomaRecruitingNCT07099547Phase 2
- A Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma.RecruitingNCT07099430Phase 1/2
- Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033Not yet recruitingNCT07097948Phase 2
- Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid TumorsRecruitingNCT07095868Phase 1/2
- Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy FailureNot yet recruitingNCT07095803Phase 2
- Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck CancerRecruitingNCT07094685Phase 2
- Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical CancerRecruitingNCT07092696Phase 2
- A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After ChemoradiotherapyRecruitingNCT07091305Phase 2
- Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ AdenocarcinomaNot yet recruitingNCT07091227Phase 2
- PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)Not yet recruitingNCT07090707Phase 2
- Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07090369Phase 1
- Iparomlimab and Tuvonralimab in HNSCCRecruitingNCT07090317Phase 2
- Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPCRecruitingNCT07090148Phase 1
- A Study of Pembrolizumab in People With Ultra-Rare SarcomasRecruitingNCT07089992Phase 2
- Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical CancerNot yet recruitingNCT07088731Phase 2
- Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCRecruitingNCT07088211Phase 2
- Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder CancersRecruitingNCT07087860Phase 2
- Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07086456Phase 2
- A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLCNot yet recruitingNCT07086326Phase 2
- Cemiplimab as Maintenance Treatment for Advanced Adrenocortical CancerRecruitingNCT07085572Phase 2
- Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPCRecruitingNCT07085234Phase 2
- Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT07084610Phase 2